. . . . . . . . . . . . . . . . . "Humans and other mammals"@en . . "Investigated for use/treatment in lymphoma (non-hodgkin's)."@en . . . . "# Klein I, Welink J, van der Vijgh WJ: Determination of Elsamitrucin (BMY-28090) in plasma and urine by high-performance liquid chromatography with fluorescence detection. J Chromatogr. 1993 Dec 22;622(2):249-53. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8150873"@en . . "Elsamitrucin induces single strand breaks in DNA and inhibits topoisomerase I and II, enzymes that play an important role in DNA replication. "@en . . . "investigational"@en . . "97068-30-9"@en . . . "The cytostatic agent Elsamitrucin is a new fermentation product active in a variety of in vivo tumor models of murine and human origin. (PMID: 8150873)"@en . . . . "Elsamitrucin"@en . . "36\u201360 h"@en . .